Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Targeting Neurological Aspects of Mucopolysaccharidosis Type II: Enzyme Replacement Therapy and Beyond ; volume:38 ; number:5 ; day:23 ; month:8 ; year:2024 ; pages:639-655 ; date:9.2024
BioDrugs ; 38, Heft 5 (23.8.2024), 639-655, 9.2024
- Creator
-
Zanetti, Alessandra
Tomanin, Rosella
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-024-00675-0
- URN
-
urn:nbn:de:101:1-2411132116184.950459997051
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zanetti, Alessandra
- Tomanin, Rosella
- SpringerLink (Online service)
Other Objects (12)
Modifying enzyme replacement therapy – a perspective
Enzyme replacement therapy: efficacy and limitations
Causal Therapies in Mucopolysaccharidoses: Enzyme Replacement Therapy
Enzyme replacement therapy (ERT) in pompe disease
Targeting pericytes for therapeutic approaches to neurological disorders
Pancreatin : enzyme replacement therapy for pancreatic exocrine insufficiency
Difficulties in treating CLN2 through enzyme replacement therapy
Improving enzyme replacement therapy for lysosomal storage diseases
Immunotherapies targeting stimulatory pathways and beyond
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia
The lysosomal storage disease fucosidosis: towards enzyme replacement therapy
Upfront Enzyme Replacement via Erythrocyte Transfusions for PNP Deficiency
Modifying enzyme replacement therapy – a perspective
Enzyme replacement therapy: efficacy and limitations
Causal Therapies in Mucopolysaccharidoses: Enzyme Replacement Therapy
Enzyme replacement therapy (ERT) in pompe disease
Targeting pericytes for therapeutic approaches to neurological disorders
Pancreatin : enzyme replacement therapy for pancreatic exocrine insufficiency
Difficulties in treating CLN2 through enzyme replacement therapy
Improving enzyme replacement therapy for lysosomal storage diseases
Immunotherapies targeting stimulatory pathways and beyond
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia
The lysosomal storage disease fucosidosis: towards enzyme replacement therapy
Upfront Enzyme Replacement via Erythrocyte Transfusions for PNP Deficiency
Modifying enzyme replacement therapy – a perspective
Enzyme replacement therapy: efficacy and limitations
Causal Therapies in Mucopolysaccharidoses: Enzyme Replacement Therapy
Enzyme replacement therapy (ERT) in pompe disease
Targeting pericytes for therapeutic approaches to neurological disorders
Pancreatin : enzyme replacement therapy for pancreatic exocrine insufficiency
Difficulties in treating CLN2 through enzyme replacement therapy
Improving enzyme replacement therapy for lysosomal storage diseases
Immunotherapies targeting stimulatory pathways and beyond
Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia
The lysosomal storage disease fucosidosis: towards enzyme replacement therapy